These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 854720)
21. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection. Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666 [TBL] [Abstract][Full Text] [Related]
22. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases. de Moura MC; Vernace SJ; Paronetto F Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122 [TBL] [Abstract][Full Text] [Related]
23. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen. Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894 [TBL] [Abstract][Full Text] [Related]
24. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus. Madalinski K; Burczynska B; Heermann KH; Uy A; Gerlich WH Clin Exp Immunol; 1991 Jun; 84(3):493-500. PubMed ID: 2044231 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus infection: detection of circulating HBsAg/IgM antibody immune complexes. Surelia P; Boxall EH Med Lab Sci; 1990 Jul; 47(3):204-9. PubMed ID: 2402200 [TBL] [Abstract][Full Text] [Related]
26. Necrosis of the hepatocytes with hepatitis B surface antigen. Occurrence in a chronic hepatitis B surface antigen carrier. Karasawa T; Shikata T Arch Pathol Lab Med; 1977 Jun; 101(6):280-5. PubMed ID: 301018 [TBL] [Abstract][Full Text] [Related]
27. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg. Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050 [TBL] [Abstract][Full Text] [Related]
29. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515 [TBL] [Abstract][Full Text] [Related]
30. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Demetris AJ; Todo S; Van Thiel DH; Fung JJ; Iwaki Y; Sysyn G; Ming W; Trager J; Starzl TE Am J Pathol; 1990 Sep; 137(3):667-76. PubMed ID: 2399936 [TBL] [Abstract][Full Text] [Related]
31. Hepatocyte hepatitis B surface antigen. Diagnostic evaluation of patients with clinically acute hepatitis B surface antigen-positive hepatitis. Su IJ; Kuo TT; Liaw YF Arch Pathol Lab Med; 1985 May; 109(5):400-2. PubMed ID: 3885902 [TBL] [Abstract][Full Text] [Related]
32. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen. Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847 [TBL] [Abstract][Full Text] [Related]
33. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
34. [Circulating immune complexes in viral hepatitis B and cellular immunity]. Belozerov ES; Makarova TA Klin Med (Mosk); 1983 Feb; 61(2):71-4. PubMed ID: 6601740 [No Abstract] [Full Text] [Related]
35. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection. Perrillo R; Campbell C; Wellinghoff W; Gelb L Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872 [TBL] [Abstract][Full Text] [Related]
37. Type B hepatitis: progression to chronic hepatitis. Wright R Clin Gastroenterol; 1980 Jan; 9(1):97-115. PubMed ID: 6994954 [TBL] [Abstract][Full Text] [Related]
38. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease. Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926 [TBL] [Abstract][Full Text] [Related]
39. Circulating HBsAg/IgM complexes in acute and chronic hepatitis B. Musca A; Cordova C; Barnaba V; Zaccari C; Levrero M; van Dyke A; Balsano F Hepatogastroenterology; 1984 Oct; 31(5):208-10. PubMed ID: 6510881 [TBL] [Abstract][Full Text] [Related]
40. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Tsai SL; Liaw YF; Yeh CT; Chu CM; Kuo GC Hepatology; 1995 Apr; 21(4):908-12. PubMed ID: 7535736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]